These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 303938)

  • 1. Changes in glomerular filtration rate associated with high-dose methotrexate therapy in adults.
    Howell SB; Carmody J
    Cancer Treat Rep; 1977 Oct; 61(7):1389-91. PubMed ID: 303938
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
    Djerassi I; Kim JS; Shulman K
    Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
    Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
    Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
    Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
    Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.
    Stoller RG; Kaplan HG; Cummings FJ; Calabresi P
    Cancer Res; 1979 Mar; 39(3):908-12. PubMed ID: 311683
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovery from toxicity associated with high-dose methotrexate: prognostic factors.
    Chan H; Evans WE; Pratt CB
    Cancer Treat Rep; 1977 Aug; 61(5):797-804. PubMed ID: 19151
    [No Abstract]   [Full Text] [Related]  

  • 8. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
    Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
    Pratt CB; Roberts D; Shanks EC; Warmath EL
    Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose methotrexate in malignant gliomas.
    Shapiro WR
    Cancer Treat Rep; 1977 Jul; 61(4):753-6. PubMed ID: 301785
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.
    Mitchell MS; Wawro NW; DeConti RC; Kaplan SR; Papac R; Bertino JR
    Cancer Res; 1968 Jun; 28(6):1088-94. PubMed ID: 4298056
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient case involving high-dose methotrexate followed by leucovorin rescue.
    Alsop JA
    Am J Hosp Pharm; 1978 Feb; 35(2):127. PubMed ID: 305201
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
    Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
    Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose intravenous methotrexate for refractory rheumatoid arthritis.
    Shiroky JB; Neville C; Skelton JD
    J Rheumatol; 1992 Feb; 19(2):247-51. PubMed ID: 1629823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mycosis fungoides lymphoma: effectiveness of infusions of methotrexate followed by oral citrovorum factor.
    McDonald CJ; Bertino JR
    Cancer Treat Rep; 1978 Jul; 62(7):1009-14. PubMed ID: 308391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
    Sirotnak FM; Moccio DM; Dorick DM
    Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate. II. Use in pediatric chemotherapy.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):397-413. PubMed ID: 6398630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.
    Jacobs SA; Santicky MJ
    Cancer Treat Rep; 1978 Mar; 62(3):397-9. PubMed ID: 348306
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose methotrexate with leucovorin rescue.
    Akahoshi M
    Cancer Nurs; 1978 Aug; 1(4):319-25. PubMed ID: 307982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.